|Bid||20.33 x 800|
|Ask||20.72 x 800|
|Day's range||20.12 - 21.15|
|52-week range||19.64 - 82.49|
|Beta (5Y monthly)||1.69|
|PE ratio (TTM)||N/A|
|Earnings date||01 Aug 2023 - 07 Aug 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||38.88|
Anyone who has followed the stock market for years will attest the market isn't always rational in the near term. At the drop of a hat, a stock can receive more praise and price appreciation than it is due, or plummet far beyond the realm of sensibility into cheap territory.
The headline numbers for Trupanion (TRUP) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Trupanion (TRUP) delivered earnings and revenue surprises of -114.29% and 1.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Trupanion (TRUP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion, Inc. ( NASDAQ:TRUP ) shareholders that were waiting for something to happen have been dealt a blow with a...
In this Motley Fool Money podcast, Motley Fool senior analysts Emily Flippen and Ron Gross join host Chris Hill to discuss: Fear of a recession vs. fear of banking contagion. Whether social media giants like Meta Platforms and Snap stand to benefit from the drama around TikTok.
Unum (UNM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
When done right, growth investing is a strategy that can be quite lucrative over the long haul. For less mature businesses not yet turning a profit in newer industries, revenue growth is a great measure of whether a business is properly executing and is a good candidate for growth investors. Pet insurer Trupanion (NASDAQ: TRUP) could fit this requirement.
Trupanion (TRUP) delivered earnings and revenue surprises of 23.33% and 1.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
By buying an index fund, investors can approximate the average market return. But if you choose individual stocks with...
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given the change in the attitude of pet owners who are increasingly focusing on pets' health and well-being.
When done right, growth investing can be very profitable. High-quality growth companies will execute on their plans and drive revenue and the stock price higher over time. The pet health insurer Trupanion (NASDAQ: TRUP) has done that for the last eight years and counting.
In an effort to curb inflation, the Federal Reserve just announced its final interest rate hike of 2022: 50 basis points, or half a percentage point. With more investors worried that the Federal Reserve won't be able to avoid a recession in its quest to tame inflation, markets have had a downright awful year. The Nasdaq Composite has plunged 29% year to date.
Aflac, Unum Group, Trupanion, Employers Holdings and AMERISAFE have been highlighted in this Industry Outlook article.
It seems logical that the smartest move is to stay away from such stocks. Good news for a stock often results in a short squeeze where the share price soars as short-sellers scramble to cover their positions. Are these three companies next on the list for short squeezes?
Trupanion ( NASDAQ:TRUP ) Third Quarter 2022 Results Key Financial Results Revenue: US$233.8m (up 29% from 3Q 2021...
Trupanion (TRUP) delivered earnings and revenue surprises of -10.34% and 1.10%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The share price for Trupanion (NASDAQ: TRUP) finished the day down 10% on Thursday. Trupanion, a pet insurer, took a hit today due to a major deal within its industry that investors viewed negatively. Chewy, an online retailer for pet products, announced a partnership with pet insurance provider and Trupanion competitor, Lemonade.
Trupanion (TRUP) is poised to grow on a change in the attitude of pet owners who are focusing on pets' health and well-being in an underpenetrated pet insurance market, product launches and extended operating boundaries.
The stock of this pet health insurer has done significantly worse than the Nasdaq Composite in recent months.
Given the extreme volatility the market has seen this year, you might be wondering whether it's still the right time to invest in the stock market. On that note, if you have $5,000 to invest in the stock market right now, here are two fantastic stocks to consider. Healthcare stocks are a wise place to park your cash in any market, bull or bear.
Investors continue to slowly move away from worries about the economy, inflation, and interest rates, sending growth stocks higher. It's not all good news and positivity, though.
Trupanion (TRUP) delivered earnings and revenue surprises of -43.48% and 1.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?